Sonoco Secures $750M Revolving Credit Facility
Packaging company Sonoco Products Co (NYSE:SON) has entered into a new five-year $750 million revolving credit facility with a syndicate of banks.…
Pulse Biosciences Stock Is Trading Higher After Company’s Chairman Agrees To Buy Shares Worth $50M
Pulse Biosciences Inc’s (NASDAQ:PLSE) Board Chairman, Robert W. Duggan, will purchase 3.04 million common shares at $16.40 per share in…
Brazilian Crypto Exchange Gets $200M Funding From SoftBank
What Happened: Latin America’s largest crypto exchange Mercado Bitcoin has raised $200 million from SoftBank Group Corp’s (OTCMKTS: SFTBY) Latin America Fund.
Kymera Prices $223M Equity Offering At $47/Share
Kymera Therapeutics Inc (NASDAQ:KYMR) has priced its upsized underwritten public offering of 4.7 million shares at $47.00 per share, representing a discount…
Aligos Therapeutics Raises $84M Via Equity At 7% Discount
Aligos Therapeutics Inc (NASDAQ:ALGS) has priced a previously announced underwritten public offering of 4.4 million shares at $19 per share, representing a…
Spero Therapeutics Stock Surges On $40M Equity Funding, SPR206 Licensing Pact With Pfizer
Spero Therapeutics Inc (NASDAQ:SPRO) announced that Pfizer Inc (NYSE: PFE) would contribute $40 million to the company through its Breakthrough Growth Initiative focusing on…
Alibaba Said To Be Making Its First Major Investment Since Antitrust Woes
Chinese e-commerce giant Alibaba Group Holding (NYSE: BABA) is set to make its first big investment since paying a record antitrust fine as part of a crackdown on the Jack Ma-led company, Bloomberg News
Drug Formulation Developer Aerovate Therapeutics Kick Starts Trading Today With Upsized Debut
Just shy of a full year after emerging from stealth mode, Aerovate Therapeutics Inc (NASDAQ: AVTE) is listing onto NASDAQ with an upsized offering.
Cannabis Co. On The Move: Columbia Care Fuels Its Growth With $74.5M Raise Through Private Placement Offering
Cannabis company Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE:3LP) has raised $74.5 million through a private placement offering of 6% secured convertible notes.
Kiromic BioPharma Stock Plunges After $40M Equity Raise Issued At 24% Discount
Kiromic BioPharma Inc (NASDAQ:KRBP) has priced an underwritten public offering of 8 million shares at $5.00 per share, for gross proceeds…